Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock
WILMETTE, Ill., Oct. 28, 2024 ( GLOBE NEWSWIRE ) -- Monopar Therapeutics Inc. ( Nasdaq: MNPR ) ( "Monopar Therapeutics" or the "Company" ) , a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical needs, today announced the pricing of ...
| Ticker |
Sentiment |
Impact |
|
JHG
|
Neutral
|
5 %
|
|
MNPR
|
Somewhat Bullish
|
38 %
|
